Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Digestive Diseases and Sciences
|
January 3, 2026
Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab Dosing
Ryan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2025
Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease
Sarah Taylor, Lynna Chen, Krishneel Dutt, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
March 11, 2026
Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population
Ryan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Alimentary Pharmacology & Therapeutics
|
May 14, 2025
Real-World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education
Sarah Taylor, Emily Barwick, Varan Perananthan, et al.
Alimentary Pharmacology & Therapeutics
|
April 30, 2020
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient
Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, et al.
Digestive Diseases and Sciences
|
March 27, 2026
The SILVER Platter for Patients with Inflammatory Bowel Disease (IBD): An IBD Pharmacy Technician-Led Subcutaneous Biologic Home Delivery Service Is Associated with Sustained Improvement in Adherence and Active Health Management
Andrew Leake, Maria Bishara, Sheng Wei Lo, et al.
Journal of Gastroenterology and Hepatology
|
October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia
Uma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Gut
|
August 15, 2019
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Mayur Garg, Simon G Royce, Chris Tikellis, et al.
BMJ Open
|
July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial
Robert D Little, Jo McKenzie, Ashish Srinivasan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Matthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Digestive Diseases and Sciences
|
January 3, 2026
Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab Dosing
Ryan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Alimentary Pharmacology & Therapeutics
|
January 10, 2025
Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease
Sarah Taylor, Lynna Chen, Krishneel Dutt, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
March 11, 2026
Rise in Admissions for Acute Severe Ulcerative Colitis at an Australian Health Service With a Culturally and Linguistically Diverse Population
Ryan Bartlett, Mustafa Mohamedrashed, Saiumaeswar Yogakanthi, et al.
Alimentary Pharmacology & Therapeutics
|
May 14, 2025
Real-World Effectiveness of Budesonide Orodispersible Tablets for Eosinophilic Oesophagitis: The Importance of Patience and Education
Sarah Taylor, Emily Barwick, Varan Perananthan, et al.
Alimentary Pharmacology & Therapeutics
|
April 30, 2020
Review article: prevention, diagnosis and management of COVID-19 in the IBD patient
Aysha H Al-Ani, Ralley E Prentice, Clarissa A Rentsch, et al.
Digestive Diseases and Sciences
|
March 27, 2026
The SILVER Platter for Patients with Inflammatory Bowel Disease (IBD): An IBD Pharmacy Technician-Led Subcutaneous Biologic Home Delivery Service Is Associated with Sustained Improvement in Adherence and Active Health Management
Andrew Leake, Maria Bishara, Sheng Wei Lo, et al.
Journal of Gastroenterology and Hepatology
|
October 10, 2025
IBD 2024: Charting a New Course in IBD Proceedings of the Takeda Symposium 22-23 November 2024 W Hotel, Brisbane, Queensland, Australia
Uma Mahadevan, Vipul Jairath, Jakob Begun, et al.
Gut
|
August 15, 2019
Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?
Mayur Garg, Simon G Royce, Chris Tikellis, et al.
BMJ Open
|
July 20, 2024
Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial
Robert D Little, Jo McKenzie, Ashish Srinivasan, et al.
The Lancet. Gastroenterology & Hepatology
|
September 5, 2024
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Matthew C Choy, Christopher F D Li Wai Suen, Danny Con, et al.
Page
of 9